etodolac has been researched along with Chronic Illness in 3 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this study was to look for correlations between the severity of chronic inflammatory joint disease and pharmacokinetic parameters of nonsteroidal antiinflammatory drugs." | 2.68 | Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac. ( Goasguen, J; Guggenbuhl, P; Jacquelinet, C; Lapicque, F; Le Dantec, P; Netter, P; Pawlotsky, Y; Perdriger, A; Veillard, E, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pawlotsky, Y | 1 |
| Le Dantec, P | 1 |
| Jacquelinet, C | 1 |
| Lapicque, F | 1 |
| Goasguen, J | 1 |
| Perdriger, A | 1 |
| Veillard, E | 1 |
| Guggenbuhl, P | 1 |
| Netter, P | 1 |
| Murakawa, Y | 1 |
| Tsutsumi, M | 1 |
| Murata, N | 1 |
| Sasaki, Y | 1 |
| Tsujiuchi, T | 1 |
| Mikasa, K | 1 |
| Narita, N | 1 |
| Konishi, Y | 1 |
| Menke, ER | 1 |
| Jackson, CR | 1 |
| Bagby, MD | 1 |
| Tracy, TS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Incidence of Postoperative Pain After Using Different Types of Sealers (A Randomized Clinical Trial)[NCT05841290] | 40 participants (Anticipated) | Interventional | 2023-05-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for etodolac and Chronic Illness
| Article | Year |
|---|---|
Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Ar | 1996 |
The effectiveness of prophylactic etodolac on postendodontic pain.
Topics: Acute Disease; Administration, Oral; Analgesics, Non-Narcotic; Analysis of Variance; Anti-Inflammato | 2000 |
1 other study available for etodolac and Chronic Illness
| Article | Year |
|---|---|
[Suppressive efffects of clarithromycin and cyclooxygenase-2 inhibitor, etodolac on N-nitrosobis(2-hydroxypropyl)amine(BHP)- induced experimental lung neoplasm in rats].
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Clarithromycin; Cyc | 2001 |